Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Commerce International Trade Administration [C-570-072]
 AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce.
 SUMMARY: The U.S. Department of Commerce (Commerce) finds that revocation of the countervailing duty (CVD) order on sodium gluconate, gluconic acid, and derivative products (sodium gluconate) from the People's Republic of China (China) would be likely to lead to continuation or recurrence of countervailable subsidies at the levels indicated in the “Final Results of Sunset Review” section of this notice.
 DATES: Applicable February 2, 2024.
 FOR FURTHER INFORMATION CONTACT: Stephanie Trejo, AD/CVD Operations, Office IV, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482-4390.


SUPPLEMENTARY INFORMATION: Background On November 13, 2018, Commerce published the CVD order on sodium gluconate from China.[1]
                    
                     On October 2, 2023, Commerce published the notice of initiation of the first sunset review of the 
                    *Order,*
                     pursuant to section 751(c) of the Tariff Act of 1930, as amended (the Act).[2]
                    
                     On October 12, 2023, Commerce received a timely notice of intent to participate from PMP Fermentation Products Inc. (the domestic interested party) within the 15-day deadline specified in 19 CFR 351.218(d)(1)(i).[3]
                    
                     The domestic interested party claimed interested party status under section 771(9)(C) of the Act and 19 CFR 351.102(b)(29)(v) as producers of the domestic like product. On November 1, 2023, Commerce received an adequate substantive response to the 
                    *Initiation Notice*
                     from the domestic interested party within the 30-day deadline specified in 19 CFR 351.218(d)(3)(i).[4]
                    
                     We received no substantive responses from any other interested parties, and no interested party requested a hearing. On November 17, 2023, Commerce notified the U.S. International Trade Commission that it did not receive an adequate substantive response from respondent interested parties, and that Commerce would conduct an expedited (120-day) sunset review of the 
                    *Order,*[5]
                    
                     pursuant to section 751(c)(3)(B) of the Act and 19 CFR 351.218(e)(1)(ii)(B)-(C). Scope of the Order The product covered by the 
                    *Order*
                     is sodium gluconate from China. For a complete description of the scope of the 
                    *Order, see*
                     the Issues and Decision Memorandum.[6] Analysis of Comments Received A complete discussion of all issues raised in this sunset review, including the likelihood of the continuation or recurrence of subsidization in the event of revocation of the 
                    *Order*
                     and the countervailable subsidy rates likely to prevail if the 
                    *Order*
                     were to be revoked, is provided in the accompanying Issues and Decision Memorandum. A list of the topics discussed in the Issues and Decision Memorandum is attached as an appendix to this notice. The Issues and Decision Memorandum is a public document and is on file electronically via Enforcement and Compliance's Antidumping and Countervailing Duty Centralized Electronic Service System (ACCESS), which is available to registered users at 
                    *https://access.trade.gov.*
                     In addition, a complete version of the Issues and Decision Memorandum can be accessed directly at 
                    *https://access.trade.gov/​public/​FRNotices/​ListLayout.aspx.* Final Results of Sunset Review Pursuant to sections 751(c)(1) and 752(b) of the Act, we determine that revocation of the 
                    *Order*
                     would be likely to lead to continuation or recurrence of countervailable subsidies at the 
                    ( print page 7376)
                    following net countervailable subsidy rates: Company
Subsidy rate
                             
                                (percent 
                                *ad valorem*)Qingdao Dongxiao Enterprise Co., Ltd
194.67Shandong Fuyang Biotechnology Co
194.67Shandong Kaison Biochemical Co Ltd
194.67Tongxiang Hongyu Chemical Co., Ltd
194.67All Others
194.67
 Administrative Protective Order This notice serves as the only reminder to parties subject to an administrative protective order (APO) of their responsibility concerning the disposition of proprietary information disclosed under APO in accordance with 19 CFR 351.305(a), which continues to govern business proprietary information in this segment of the proceeding. Timely written notification of the destruction of APO materials or conversion to judicial protective order is hereby requested. Failure to comply with the regulations and terms of an APO is a violation which is subject to sanction. Notification to Interested Parties Commerce is issuing and publishing these final results and this notice in accordance with sections 751(c), 752(b), and 777(i)(1) of the Act and 19 CFR 351.218. Dated: January 29, 2024. Abdelali Elouaradia, Deputy Assistant Secretary for Enforcement and Compliance.
 Appendix List of Topics Discussed in the Issues and Decision Memorandum I. Summary II. Background III. Scope of the 
                        *Order* IV. History of the 
                        *Order* V. Legal Framework VI. Discussion of the Issues 1. Likelihood of Continuation or Recurrence of a Countervailable Subsidy 2. Net Countervailable Subsidy Rates Likely To Prevail 3. Nature of the Subsidies VII. Final Results of Sunset Review VIII. Recommendation


# Footnotes

1.
    
                         
                        *See Sodium Gluconate, Gluconic Acid and Derivative Products from the People's Republic of China: Antidumping and Countervailing Duty Orders,*83 FR 56299 (November 13, 2018) (
                        *Order*). Back to Citation
 2.
    
                         
                        *See Initiation of Five-Year (Sunset) Reviews,*88 FR 67729 (October 2, 2023). Back to Citation
 3.
    
                         
                        *See*
                         Domestic Interested Parties' Letter, “Sodium Gluconate, Gluconic Acid, and Derivative Products from the People's Republic of China—Domestic Interested Parties' Notice of Intent to Participate,” dated October 12, 2023. Back to Citation
 4.
    
                         
                        *See*
                         Domestic Interested Parties' Letter, “Sodium Gluconate, Gluconic Acid, and Derivative Products from the People's Republic of China—Domestic Interested Parties' Substantive Response,” dated November 1, 2023. Back to Citation
 5.
    
                         
                        *See*
                         Commerce's Letter, “Sunset Reviews Initiated on October 2, 2023,” dated November 17, 2023. Back to Citation
 6.
    
                         
                        *See*
                         Memorandum, “Decision Memorandum for the Final Results of the First Expedited Sunset Review of the Antidumping Duty Orders on Sodium Gluconate, Gluconic Acid and Derivative Products from the People's Republic of China,” dated concurrently with, and hereby adopted by, this notice (Issues and Decision Memorandum). Back to Citation


[FR Doc. 2024-02116 Filed 2-1-24; 8:45 am] BILLING CODE 3510-DS-P